StockpollyBeta
Get App
Popularity #1,678
VSTM · NASDAQ · Biotechnology

Verastem (VSTM)

Markets AVMAPKI FAKZYNJA and develops small-molecule drugs for RAS/MAPK-driven cancers.

$8.37
After hours−0.01 (−0.12%)
At close$8.38(+4.88%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue00010000211181940
Cost of revenue000000002334
Gross profit00010000210151636
213128283732444550566169
Research & development142318182521292529323841
7910101211152121242227
General & administrative0000000000027
Other expenses000000000000
Operating income−21−31−28−18−37−32−44−44−41−41−45−33
14−61013−33−818−5898−1
Interest income221111111111
Interest expense111111000000
Other non-operating income−2−55−11−14328−1858−9−91
Income before tax−20−27−34−8−24−64−52−26−99−33−37−34
Income tax expense000000000001
Net income from continuing operations−20−27−34−8−24−65−52−26−99−33−37−35
Net income−20−27−34−8−24−65−52−26−99−33−37−35
EPS, basic−$0.75−$1.02−$1.26−$0.31−$0.60−$1.70−$0.96−$0.39−$1.35−$0.39−$0.37−$0.35
EPS, diluted−$0.75−$1.02−$1.26−$0.31−$0.60−$1.70−$0.96−$0.32−$1.35−$0.39−$0.37−$0.35
Weighted average shares, basic2727272740385466738398100
Weighted average shares, diluted2727272740385474738399100
EBITDA−19−26−33−7−23−63−52−26−98−32−36−33
Depreciation & amortization000000000000
EBIT−19−26−33−7−23−63−52−26−99−33−36−33